Brief: Trinity Biotech Announces Q3 2022 Financial Results
15/12/2022 14:44
Dec 15 (Reuters) - Trinity Biotech PLC TRIB.O :
* TRINITY BIOTECH ANNOUNCES Q3 2022 FINANCIAL RESULTS
* TRINITY BIOTECH PLC - TOTAL REVENUES FOR Q3 2022 WERE
$19.5MLN
* TRINITY BIOTECH PLC - DILUTED LOSS PER ADS FOR Q3, 2022
WAS 23.5
CENTS
Source text for Eikon: ID:nGNX7MgY71
Further company coverage: TRIB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trinity Biotech
See all newsNASDAQ RESUMED AT 12:18 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:13 PM
Brief: Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update
Brief: Trinity Biotech’S Trinovium Subsidiary Agrees To Collaborate With Echelon Data Centres To Develop Advanced Liquid Cooling Solutions For Ai Infrastructure
NASDAQ RESUMED AT 09:00 AM